作者:Estefania Menéndez-Pedregal、Josefina Díez、Ángel Manteca、Jesús Sánchez、Ana C. Bento、Rósula García-Navas、Faustino Mollinedo、M. Pilar Gamasa、Elena Lastra
DOI:10.1039/c3dt51160j
日期:——
New ruthenium complexes containing enantiopure 2,6-bis[4′(R)-phenyloxazolin-2′-il-pyridine] ((R,R)-Ph-pybox), 2,6-bis[4′(S)-isopropyloxazolin-2′-il-pyridine] ((S,S)-iPr-pybox) or 2,6-bis[4′(R)-isopropyloxazolin-2′-il-pyridine] ((R,R)-iPr-pybox) and water soluble 1,3,5-triaza-7-phosphaadamantane (PTA) or N-substituted PTA phosphanes have been synthesized in high yields and fully characterized. The interactions
含有对映体纯的2,6-双[4'(R)-苯恶唑啉-2'-il-吡啶]((R,R)-Ph-pybox),2,6-双[4'(S)-异丙基恶唑啉-2'-il-吡啶]((S,S)-i Pr-pybox)或2,6-双[4'(R)-异丙基恶唑啉-2'-il-吡啶](((R,R)-一世Pr-pybox和水溶性1,3,5-triaza-7-phosphaadamantanetan(PTA)或N-取代的PTA膦已被高收率合成并充分表征。这些化合物与质粒DNA的相互作用及其对人宫颈癌HeLa细胞系的细胞毒活性已有报道,这首次指出了钌对映体的不同行为会影响HeLa肿瘤细胞的细胞周期。